FRANKFURT (Reuters) -Germany's federal drug regulator on Wednesday urged pharmacies and drug distributors to be vigilant after wholesale batches of counterfeit versions of Novo Nordisk's diabetes drug Ozempic were found in the country. In a statement, BfArM said it will lead the investigation, taking over from regional state authorities that were previously in charge of the probe. BfArM said there was no evidence that any fake Ozempic had been sold, but distributors and pharmacies should be on t